Paxman AB

31
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0009806284
SEK
48.80
-0.2 (-0.41%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Paxman AB Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-10.00
41.00
7.00
-8.00
-12.00
-20.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-15.00
-18.00
-11.00
-3.00
-4.00
-1.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
7.00
32.00
15.00
2.00
-4.00
-8.00
Cash Flow from Investing Activities
-33.00
-18.00
-25.00
-36.00
-24.00
-6.00
Cash Flow from Financing Activities
108.00
0.00
-3.00
0.00
97.00
16.00
Net Cash Inflow / Outflow
80.00
15.00
-13.00
-34.00
68.00
1.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-2.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in SEK Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Paxman AB
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(SEK)
Change(%)
Profit Before Tax
-10.599
-38.21284
28.00
72.26%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-15.747
-21.776235
6.00
27.69%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
7.387
-52.6769
59.00
114.02%
Cash Flow from Investing Activities
-33.508
-6.540077
-27.00
-412.35%
Cash Flow from Financing Activities
108.831
67.331149
41.00
61.64%
Net Cash Inflow / Outflow
80.524
8.168072
72.00
885.84%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-2.186
0.0539
-2.00
-4155.66%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is -77.36% vs 108.71% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
7.39
32.62
-77.36%